WHO issues new guidance to enhance clinical trials worldwide

The World Health Organization (WHO) today released guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels.

Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more – Psychedelic Alpha

On Saturday October 7th California’s Governor, Gavin Newsom, returned Senate Bill 58 to the Senate without his signature, effectively vetoing it. As a reminder, SB

October 31, 2023

Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer

The use of completion axillary lymph node dissection (cALND) to determine the need for adjuvant abemaciclib (Verzenio) among women with luminal estrogen receptor (ER)-positive, HER2-negative

August 10, 2024

DMTs are major clinical research focus for Parkinson’s disease, analysis shows – Pharmaceutical Technology

The World Health Organisation estimated that over 8.5 million people had PD in 2019. Credit: LE Photo / Shutterstock. Pipeline treatments across the seven major

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.